Verition Fund Management
CBAY

Verition Fund Management’s Cymabay Therapeutics CBAY Stock Holding History

Verition Fund Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-150,000
Closed -$524K – 1430
2020
Q2 		$524K Buy
+150,000
New +$433K 0.02% 590

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's CBAY Position: Q1 2024 in Review

Verition Fund Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 10,170 shares — an estimated $240K sold.

Verition Fund Management first reported a position in CBAY in Q1 2018 and held it in 8 quarters. The position peaked at $2.1M in Q2 2020. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Verition Fund Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Verition Fund Management sold 10,170 Cymabay Therapeutics shares in Q1 2024, an estimated $240K.
  • Verition Fund Management first reported a position in Cymabay Therapeutics in Q1 2018 and held it in 8 quarters.
  • Verition Fund Management's Cymabay Therapeutics position peaked at $2.1M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Verition Fund Management's 13F filing for Q1 2024, filed 14 May 2024.